Solarbetriebenes Krypto-Mining:
Die Strategie, die diese Aktie um 75 % steigen ließ!
Anzeige
SIRONA BIOCHEM WKN: A0RM6R ISIN: CA82967M1005 Forum: Aktien Thema: Hauptdiskussion
0,0475 EUR
-6,40 %-0,0033
19. Nov, 20:30:57 Uhr,
L&S Exchange
Kommentare 98.169
H
HAI90,
16.02.2024 16:57 Uhr
0
Early 2025 heißt ungefähr soviel wie soon in 2025 ? 😁
gr0unding,
16.02.2024 16:33 Uhr
0
Sirona Biochem Announces Plans For Commercial Launch of GlycoProteMim TFC-1326 in Early 2025
Sirona Biochem Corp. is pleased to announce the planned commercialization of GlycoProteMim™ through its subsidiary Sirona Laboratories. The company's Chief Scientific Officer, Dr. Geraldine Deliencourt-Godefroy, outlined the plan in a recent exclusive video interview with the Investing News Network.
In the interview, Dr. Deliencourt-Godefroy explained the company's plan to introduce a new line of anti-aging products containing GlycoProteMim™ under Sirona Laboratories. She explained that the products are scheduled to hit the North American, Canadian, and European markets in 2025.
Sirona Laboratories' product line is not just a collection of skincare essentials; but also a testament to our unwavering commitment to pushing the boundaries of anti-aging and cosmetic science.
The product line will include a 21-day ampoule anti-aging program pack, anti-aging facial creams, and an anti-wrinkle moisturizing hand cream, all of which will contain unique formulations with varying concentrations of GlycoProteMim™. Development and tests for the different product formulations are still ongoing.
Future Therapeutic Skincare Products
Anticellulite Treatment
Sirona Biochem is also advancing efforts to bring to market a distinct and innovative active compound, specially designed to effectively target and treat cellulite. A clinical trial is being scheduled. Once regulatory approval is obtained, the active will be used in a cream or serum that will become part of Sirona Laboratories' growing product line.
Given the absence of effective treatments in the market, our forthcoming potential solution for cellulite elimination presents a significant commercial opportunity.
r
rockharders,
16.02.2024 16:05 Uhr
0
schaut richtig madig aus, die verpackungen🤣
PeterG,
16.02.2024 15:56 Uhr
0
Ne, habe doch gesagt dass ich keinen Pfennig mehr in Sirona reinstecke. Wollte nur sagen dass jeder theoretisch seine Chance hatte... 😉
s
p
n
new_investor,
16.02.2024 12:43 Uhr
0
Letztes hatte jeder die Möglichkeit beim convertible offering mitzumachen. Da gab es ebenfalls Cash und Anteile 🤷♂️
Meistdiskutiert
|
Thema | ||
---|---|---|---|
1 | MicroStrategy | +11,57 % | |
2 | NVIDIA Hauptdiskussion | +4,33 % | |
3 | Marathon Digital Holdings | +12,13 % | |
4 | Super Micro Computer Hauptdiskussion | +30,60 % | |
5 | BTC/USD Hauptdiskussion | +3,42 % | |
6 | Wolfspeed | -6,32 % | |
7 | GERRESHEIMER Hauptdiskussion | -1,15 % | |
8 | Zeta Global Holdings | +8,11 % | |
9 | BAYER Hauptdiskussion | +0,69 % | |
10 | Zukunft Ocugen | -5,26 % | Alle Diskussionen |
Aktien
|
Thema | ||
---|---|---|---|
1 | MicroStrategy | +11,56 % | |
2 | NVIDIA Hauptdiskussion | +4,33 % | |
3 | Marathon Digital Holdings | +11,29 % | |
4 | Super Micro Computer Hauptdiskussion | +30,53 % | |
5 | Wolfspeed | -6,19 % | |
6 | GERRESHEIMER Hauptdiskussion | -1,36 % | |
7 | BAYER Hauptdiskussion | +0,37 % | |
8 | Zeta Global Holdings | +7,57 % | |
9 | Zukunft Ocugen | -5,31 % | |
10 | Lilium Aktie | +102,50 % | Alle Diskussionen |